SOTIO is negotiating a partnership with pharmaceutical companies
in the field of cancer drug testing. This was confirmed to ČIANEWS
by SOTIO spokesman Richard Kapsa, stating that the company has been cooperating with companies developing innovative anti-cancer
products for many years. These include for instance the Swiss NBETherapeutics.
In 2020, SOTIO began construction of a specialized
centre for T cell therapies, including research laboratories, in
Camebridge, USA. At the same time, it is preparing for possible
admission to a stock exchange in the USA. (Source: ČIA News, www.cianews.cz/en)